Progress in transduction of cerebellar Purkinje cells in vivo using viral vectors

被引:27
作者
Hirai, Hirokazu [1 ,2 ,3 ]
机构
[1] Gunma Univ, Grad Sch Med, Dept Neurophysiol, Gunma 3718511, Japan
[2] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan
[3] Japan Sci & Technol Agcy, SORST, Saitama, Japan
关键词
Purkinje cell; viral vector; lentivirus; adeno-associated virus; gene therapy;
D O I
10.1007/s12311-008-0012-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Expression of a foreign gene in cerebellar Purkinje cells in vivo is a powerful method for exploring the pathophysiology of the cerebellum. Although using developmental engineering many gene-modified mice have been generated, this approach is time-consuming and requires a lot of effort for crossing different lines of mice, genotyping and maintenance of animals. If a gene of interest can be transferred to and efficiently expressed in Purkinje cells of developing and mature animals, it saves much time, effort and money. Recent advances in viral vectors have markedly contributed to selective and efficient gene transfer to Purkinje cells in vivo. There are two approaches for selective gene expression in Purkinje cells: one is to take advantage of the viral tropism for Purkinje cells, which includes the tropism of adeno-associated virus and the vesicular stomatitis virus glycoprotein (VSV-G)-pseudotyped lentivirus. Another method, which might be used in combination with the first one, is utilization of a Purkinje-cell-specific promoter. Focusing mainly on these points, recent progress in viral-vector-mediated transduction of Purkinje cells in vivo is reviewed.
引用
收藏
页码:273 / 278
页数:6
相关论文
共 31 条
[1]   Highly efficient and specific gene transfer to Purkinje cells in vivo using a herpes simplex virus I amplicon [J].
Agudo, M ;
Trejo, JL ;
Lim, F ;
Avila, J ;
Torres-Alemán, I ;
Diaz-Nido, J ;
Wandosell, F .
HUMAN GENE THERAPY, 2002, 13 (05) :665-674
[2]   Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors [J].
Alisky, JM ;
Hughes, SM ;
Sauter, SL ;
Jolly, D ;
Dubensky, TW ;
Staber, PD ;
Chiorini, JA ;
Davidson, BL .
NEUROREPORT, 2000, 11 (12) :2669-2673
[3]   Selective and rapid uptake of adeno-associated virus type 2 in brain [J].
Bartlett, JS ;
Samulski, RJ ;
McCown, TJ .
HUMAN GENE THERAPY, 1998, 9 (08) :1181-1186
[4]   Transduction of brain by herpes simplex virus vectors [J].
Berges, Bradford K. ;
Wolfe, John H. ;
Fraser, Nigel W. .
MOLECULAR THERAPY, 2007, 15 (01) :20-29
[5]   Assessment of CMV, RSV and SYN1 promoters and the woodchuck post-transcriptional regulatory element in adenovirus vectors for transgene expression in cortical neuronal cultures [J].
Boulos, Sherif ;
Meloni, Bruno P. ;
Arthur, Peter G. ;
Bojarski, Christina ;
Knuckey, Neville W. .
BRAIN RESEARCH, 2006, 1102 :27-38
[6]   Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or-2 serotypes for widespread gene delivery to the neonatal mouse brain [J].
Broekman, MLD ;
Comer, LA ;
Hyman, BT ;
Siena-Esteves, M .
NEUROSCIENCE, 2006, 138 (02) :501-510
[7]   Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system [J].
Burger, C ;
Gorbatyuk, OS ;
Velardo, MJ ;
Peden, CS ;
Williams, P ;
Zolotukhin, S ;
Reier, PJ ;
Mandel, RJ ;
Muzyczka, N .
MOLECULAR THERAPY, 2004, 10 (02) :302-317
[8]   Gene transfer into neurons from hippocampal slices:: Comparison of recombinant Semliki Forest virus, adenovirus, adeno-associated virus, lentivirus, and measles virus [J].
Ehrengruber, MU ;
Hennou, S ;
Büeler, H ;
Naim, HY ;
Déglon, N ;
Lundstrom, K .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2001, 17 (05) :855-871
[9]   Adeno-associated viruses undergo substantial evolution in primates during natural infections [J].
Gao, GP ;
Alvira, MR ;
Somanathan, S ;
Lu, Y ;
Vandenberghe, LH ;
Rux, JJ ;
Calcedo, R ;
Sanmiguel, J ;
Abbas, Z ;
Wilson, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (10) :6081-6086
[10]   A neural cell-type-specific expression system using recombinant adenovirus vectors [J].
Hashimoto, M ;
Aruga, J ;
Hosoya, Y ;
Kanegae, Y ;
Saito, I ;
Mikoshiba, K .
HUMAN GENE THERAPY, 1996, 7 (02) :149-158